Author:
Luo Xin,Wang Xiaomin,Xia Zhengyuan,Chung Sookja Kim,Cheung Chi Wai
Abstract
AbstractThe roles of chemokine C-X-C motif ligand 12 (CXCL12) and its receptor chemokine C-X-C motif receptor 4 (CXCR4) reveal this chemokine axis as an emerging neuromodulator in the nervous system. In the peripheral and central nervous systems, both CXCL12 and CXCR4 are expressed in various kinds of nociceptive structures, and CXCL12/CXCR4 axis possesses pronociceptive property. Recent studies have demonstrated its critical roles in the development and maintenance of pathological pain, and both neuronal and glial mechanisms are involved in this CXCL12/CXCR4 axis-mediated pain processing. In this review, we summarize the recent development of the roles and mechanisms of CXCL12/CXCR4 axis in the pathogenesis of chronic pain by sciatic nerve injury, human immunodeficiency virus-associated sensory neuropathy, diabetic neuropathy, spinal cord injury, bone cancer, opioid tolerance, or opioid-induced hyperalgesia. The potential targeting of CXCL12/CXCR4 axis as an effective and broad-spectrum pharmacological approach for chronic pain therapy was also discussed.
Reference128 articles.
1. released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury;Van Steenwinckel;Neurosci,2011
2. The biology of HIV;Alkhatib;AIDS,2009
3. in patients with spinal cord injury;Finnerup;Pain Pain,2013
4. models of neuropathic pain;Jaggi;Animal Clin Pharmacol,2011
5. Increased chemokine signaling in a model of HIV associated peripheral neuropathy;Bhangoo;Mol Pain,2009
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献